RAPP
Rapport Therapeutics
RAPP
RAPP
70 hedge funds and large institutions have $649M invested in Rapport Therapeutics in 2024 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
22.43% more ownership
Funds ownership: 77.57% → 99.99% (+22%)
12% more capital invested
Capital invested by funds: $580M → $649M (+$68.4M)
Holders
70
Holding in Top 10
5
Calls
$4K
Puts
–
Top Buyers
| 1 | +$3.2M | |
| 2 | +$2.05M | |
| 3 | +$1.94M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.7M |
| 5 |
Jennison Associates
New York
|
+$1.1M |
Top Sellers
| 1 | -$7.75M | |
| 2 | -$2.26M | |
| 3 | -$1.6M | |
| 4 |
MS
Maven Securities
St Helier,
Jersey
|
-$613K |
| 5 |
WG
Winton Group
London,
United Kingdom
|
-$494K |